Course Date: 11th November 2009
Course Duration: 1 day
Location: Royal Society of Medicine
1 Wimpole Street
London W1G 0AE
Country: UNITED KINGDOM
Price: RSM Members
Fellow: £145 (£125 before 9 October 2009)
Associate: £115 (£100 before 9 October 2009)
Trainee: £115 (£100 before 9 October 2009)
Retired: £115 (£100 before 9 October 2009)
Student: £45 (£30 before 9 October 2009)
Non RSM Members
Doctor/Consultant/Medical Professional: £265 (£225 before 9 October 2009)
Allied Health Professional: £135 (£115 before 9 October 2009)
Nurse: £135 (£115 before 9 October 2009)
Trainee: £135 (£115 before 9 October 2009)
Student: £60 (£40 before 9 October)
Course objectives:
The programme attempts to provide a comprehensive update on the key advances in a variety of areas of research, both basic and clinical, which underpin developments in approaches to management. It aims to provide delegates with a rounded, interdisciplinary view of the underlying neurobiology, and current approached to the optimal clinical investigation an treatment of cerebral tumours; and bring together those active in basic clinical research with all clinicians involved in the management of patients with brain tumours.
Speakers include:
Professor Michael Brada
Dr Susan Short
Professor Alan Jackson
Dr Jeremy Rees
Professor Peter Collins
Professor Dr Martin J van den Bent
Dr Adam Waldman
Target audience:
This wide-ranging programme is designed to have broad appeal to all those involved in research and treatment of brain tumours. Those who should attend include neuroscientists, neurologists, neurosurgeons, neuro-radiologists, neuro-pathologists, oncologists, trainees in all these specialities, palliative care physicians and specialist nurses.
Topics covered:
Cancer stem cells and the origins of astrocytomas
Molecular and imaging biomarkers, with specific reference to their relevance to patient stratification in clinical trials, the development of new treatments and assessment of treatment response in clinical practice
Advances in surgical treatment
Advances in radiotherapy and radiobiology
The modern approach to the management of cerebral metastases; this has become an increasingly important topic as more and more patients with systematic cancers are developing cerebral metastatic disease, following the advent of new biological treatments
Advance in paediatric neuro-oncology to keep adult clinicians abreast of developments in childhood cerebral tumours
Sirvice developments for the treatment of patients with brain tumours, driven by the NICE Improving Outcomes Guidance document
Language:
English
CME points:
5 points (applied for)
Contact person name: Ken Savage-Brookes
Contact person phone: +44 (0)20 7290 3947
Contact person email: ken.savage-brookes@rsm.ac.uk
 |
 |  |
 |
